• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION ABACUS SOFTWARE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION ABACUS SOFTWARE Back to Search Results
Model Number 8300-0169
Device Problems Use of Incorrect Control/Treatment Settings (1126); Programming Issue (3014)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
No product was returned and because a serial number was not provided, a manufacturing review could not be performed.However, based on the customer report, this event was determined to be related to user error.The facility will be switching from aminosyn ii 10% to travasol 10% and will set up appropriate curve data for travasol.The abacus user guide directs users to thoroughly review all data because serious harm or death may occur if an adequate review isn't completed.The abacus software changes an order to complete only after an authorized user completely finishes and approves an order.A thorough review of all data on each tab in the order entry process will minimize the risk of medication error.The abacus user guide also warns that users should keep in mind the potential of precipitate formation during parenteral nutrition admixture, even when using appropriate curve data, and that decisions regarding drug therapy must be based on professional judgment.This event is logged under complaint file (b)(4).
 
Event Description
The customer reported that when entering orders containing aminosyn ii 10% into abacus, they were using clinamix 10% curve data since they did not have curve data for aminosyn ii 10%.Curve data represents a comparison of a given tpn order to calcium phosphate solubility, as specified by drug/solution templates provided by manufacturers.This data is presented in abacus as a graph showing the likelihood of precipitation formation in the order.In this situation, using inaccurate curve data could result in the formation of precipitate in the compounded product.The compounded product was released for patient use.However, there was no report of patient injury or adverse event in relation to this event.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABACUS SOFTWARE
Type of Device
ABACUS SOFTWARE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
14445 grasslands drive
englewood CO 80112
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
14445 grasslands drive
englewood CO 80112
Manufacturer Contact
tracey hughes
9540 maroon circle
suite 400
englewood, CO 80112
3033909898
MDR Report Key4954875
MDR Text Key23226434
Report Number1419106-2015-00156
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Reporter Country CodeBD
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Pharmacist
Report Date 07/30/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Pharmacist
Device Model Number8300-0169
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/30/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-